The vast majority of children who develop Hodgkin lymphoma beat the blood cancer after treatment, which includes powerful radiation. A new study looked at how that therapy affected young patients later in life.

A new type of medication that disables lymphoma tumor cells has shown considerable success for patients who were not responding to other treatments.

Myelofibrosis is a type of chronic leukemia that attacks bone marrow. Researchers at Mayo Clinic showed promising study results for one treatment for this disease.

A medication taken off the market in 2010 may have a new use in treating children with an aggressive form of blood cancer.

To avoid potentially lethal complications, stem cell transplants had to use cells donated by relatives of the patient or perfectly matched donors. Not anymore. Researchers are expanding the possibilities.

Stem cell transplants that replace damaged blood cells with healthy ones can be life-saving procedures for people living with blood cancers. Advances have made stem cell transplants available to more people.

Stem cell transplants are potentially curative treatments for blood cancer patients. But a common side effect of this procedure, called graft-versus-host disease, can be very serious, even deadly.

Living with allergies can be annoying. Now, a study has found that women with common allergies may possibly have more than itchy eyes and sneezing to worry about.

Therapies that are successful in wiping out childhood leukemia can impact the health of survivors years down the road. New research found that heart problems can begin to appear in survivors even during childhood.

Lymphomas are blood cancers that start in the cells of the immune system. Burkitt’s lymphoma is a particularly aggressive form of the disease. New research may have discovered a better way to treat it.